Latest News
Standard Life to take £40m hit as Lloyds pulls funds
Standard Life Aberdeen (SLA) said it was making an impairment charge of around £40m after Lloyds Bank announced it was withdrawing an estimated £100bn in funds controlled by its Scottish Widows investment arm.
London open: Stocks rise as investors shrug off US inflation data; miners gain
London stocks rose in early trade on Thursday, taking their cue from a positive session in the US, where investors shrugged off a rise in inflation, with miners lending support.
Chemical tanker market remains 'challenging', says Odfjell
Chemicals and bulk liquids shipping giant Odfjell reported its fourth quarter results on Thursday, which the board said reflected a “challenging” chemical tanker market with some seasonal improvements.
Oxford BioMedica signs collaboration agreement with Bioverativ
Gene and cell therapy group Oxford BioMedica announced on Thursday that it has completed a major new collaboration and licence agreement with Bioverativ, for the development and manufacture of lentiviral vectors to treat haemophilia.
Addex Therapeutics raising £41m to advance drug candidates
Oral allosteric modulators developer Addex Therapeutics announced on Thursday that it was seeking shareholder approval to increase its share capital by issuing up to 12,779,553 new shares at a price of CHF3. 13.
Santhera enters agreement with Polyphor to licence POL6014
Santhera Pharmaceuticals announced on Thursday that it has entered into a license agreement with Polyphor for POL6014, a clinical stage selective inhibitor of human neutrophil elastase with the potential to treat cystic fibrosis (CF) and other neutrophilic pulmonary diseases such as non-cystic fibrosis bronchiectasis (NCFB), alpha-1 antitrypsin deficiency (AATD) and primary ciliary dyskinesia (PCD).
ConvaTec results hit by supply problems; sees tough 2018 H1
Medical equipment maker ConvaTec on Thursday said its 2018 first half would be hit by the problems that led to a profits warning last year, as supply issues continued to weigh on the catheter and colostomy bag maker.
Lancashire Holdings swing to loss as catastrophes take their toll
FTSE 250 insurer Lancashire Holdings said on Thursday that it swung to a full-year loss as it took a hit from natural catastrophes.
GKN makes latest play in Melrose takeover ping-pong
GKN made efforts to return the ball back over the net on Thursday, as its ping-pong match with Melrose over the latter’s takeover proposals continued.
AVEVA's merger target at Schneider sees some good growth
Engineering data and design IT systems provider AVEVA Group noted the announcement on Thursday of the Schneider Electric financial results for the calendar year 2017, which included commentary on the performance of its industrial software portfolio.
RELX hikes final dividend, proposes merger of UK and Dutch parents
RELX Group, the information and analytics formerly known as Reed Elsevier, lifted its final dividend 10%, pledged to repeat its £700m share buyback in 2018 and proposed to merge its UK and Dutch parent companies in a further simplification of its corporate structure.
AstraZeneca's selumetinib gets FDA designation for new treatment
AstraZeneca, along with Merck & Co, announced on Thursday that the US Food and Drug Administration has granted Orphan Drug Designation (ODD) for selumetinib, a MEK 1/2 inhibitor, for the treatment of neurofibromatosis type 1 (NF1).
NewRiver buys 2 retail parks for £26.5
NewRiver real estate trust said it had bought two retail parks for a combined £26. 5m, representing an initial yield of 8. 9% and a capital value of 141 per sq ft.
London pre-open: Stocks seen higher as investors shrug off US CPI
London stocks looked set for a positive open on Thursday, taking their cue from the US, where investors shrugged off a rise in inflation.
Thursday newspaper round-up: Wages, sterling, Sky, food warning, Booker
Britain is set for a pay rise as the world economy lifts growth and falling migration makes it harder for companies to find cheap foreign labour. A report by the regional agents of the Bank of England suggests firms expect to give the average worker a 3. 1 per cent pay rise in 2018, compared to 2. 6 per cent last year, amid the strongest growth for a decade. - Daily Mail.
US close: Markets finish Wednesday well into the green
Markets recorded another positive session on Wall Street on Wednesday, although there was some volatility after the release of the latest inflation figures.